share_log

HC Wainwright & Co. Reiterates Buy on Finch Therapeutics Gr, Maintains $7 Price Target

Benzinga ·  May 12, 2023 09:31

HC Wainwright & Co. analyst Vernon Bernardino reiterates Finch Therapeutics Gr (NASDAQ:FNCH) with a Buy and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment